AllianceBernstein’s UroGen Pharma URGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$821K Hold
35,040
﹤0.01% 2423
2025
Q4
$821K Hold
35,040
﹤0.01% 2433
2025
Q3
$699K Hold
35,040
﹤0.01% 2510
2025
Q2
$480K Sell
35,040
-35,377
-50% -$339K ﹤0.01% 2661
2025
Q1
$779K Sell
70,417
-128,842
-65% -$1.37M ﹤0.01% 2359
2024
Q4
$2.12M Buy
199,259
+175,859
+752% +$2.11M ﹤0.01% 1928
2024
Q3
$297K Sell
23,400
-10,830
-32% -$161K ﹤0.01% 2924
2024
Q2
$574K Buy
+34,230
New +$487K ﹤0.01% 2599
2022
Q2
Sell
-24,500
Closed -$213K 3383
2022
Q1
$213K Hold
24,500
﹤0.01% 2978
2021
Q4
$233K Hold
24,500
﹤0.01% 3018
2021
Q3
$412K Hold
24,500
﹤0.01% 2834
2021
Q2
$374K Buy
24,500
+2,600
+12% +$47K ﹤0.01% 2933
2021
Q1
$427K Hold
21,900
﹤0.01% 2732
2020
Q4
$395K Hold
21,900
﹤0.01% 2705
2020
Q3
$422K Hold
21,900
﹤0.01% 2612
2020
Q2
$572K Hold
21,900
﹤0.01% 2518
2020
Q1
$391K Hold
21,900
﹤0.01% 2478
2019
Q4
$731K Hold
21,900
﹤0.01% 2406
2019
Q3
$522K Hold
21,900
﹤0.01% 2526
2019
Q2
$787K Buy
+21,900
New +$807K ﹤0.01% 2415

Other funds holding URGN